Actively Recruiting
Virtual Reality Rehabilitation for Stroke Patients in the Hospital and at Home.
Led by Nova Scotia Health Authority · Updated on 2026-03-18
40
Participants Needed
1
Research Sites
84 weeks
Total Duration
On this page
Sponsors
N
Nova Scotia Health Authority
Lead Sponsor
A
Acadia University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to test whether a low-cost virtual reality (VR) motor rehabilitation platform can improve motor recovery in people recovering from a first-time ischemic stroke both in the hospital and at home. The study focuses on adults aged 18 and older who have experienced moderate to severe upper limb motor deficits. The main questions it aims to answer are: * Can VR-based motor therapy improve upper limb motor function compared to standard care? * Is VR-based motor therapy a feasible and acceptable treatment option for stroke patients? Researchers will compare patients receiving VR therapy to those receiving standard care to see if the VR therapy leads to greater improvements in motor recovery and more positive patient experiences. Participants will: * Complete standardized assessments of motor function and quality of life at multiple time points. * Participate in VR therapy sessions (if in the treatment group), using gamified activities designed to improve upper limb movement. * Provide feedback on their experience with the VR system, including ease of use, motion sickness, and engagement. This study will help determine whether VR-based rehabilitation can be a practical, effective way to improve access to therapy and recovery outcomes for stroke patients, especially in rural settings with limited rehabilitation resources.
CONDITIONS
Official Title
Virtual Reality Rehabilitation for Stroke Patients in the Hospital and at Home.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of first-time ischemic stroke involving the middle cerebral artery, confirmed by CT or MRI
- Score between 6 and 40 on Fugl-Meyer Assessment's Upper Limb Extremity Subscore, indicating moderate to severe motor deficit
- Ability and willingness to provide consent (score of 18 or more on Montreal Cognitive Assessment) or assent with consent by authorized third party
- Inpatient arm: less than 5 weeks since stroke onset with admission to Valley Regional Hospital in Kentville, NS, Canada
- Outpatient arm: less than 3 months since stroke onset with discharge to home setting within 1 hour drive of Valley Regional Hospital in Kentville, NS, Canada
You will not qualify if you...
- Brainstem, cerebellar, or bilateral stroke lesion
- Secondary neurological condition such as Parkinson's disease
- Musculoskeletal injuries interfering with task performance
- Uncorrected visual deficit due to stroke or other causes
- Apraxia as identified by clinical assessment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Valley Regional Hospital
Kentville, Nova Scotia, Canada, B4N 5E3
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here